Wilms tumors. Diagnosis and therapy;Wilms-tumoren. Diagnostik und therapie

Urologe - Ausgabe A

Volumn 42, Issue 3, 2003, Pages 391-409

  Graf, N ^a   Reinhard, H ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Delayed effects; Diagnosis; Nephroblastoma; Prognosis; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CONTRAST MEDIUM; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

AGE DISTRIBUTION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; IN VIVO STUDY; NEPHROBLASTOMA; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE; PATHOGENESIS; PREVALENCE; PROGNOSIS; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037565263     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-003-0305-8     Document Type: Review

References (30)

1. Argani P, Perlman EJ, Breslow NE et al. (2000) Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms' Tumor Study Group Pathology Center. Am J Surg Pathol 24:4-18
2. Beckwith JB (1982) Histopathological aspects of renal tumors in children. Prog Clin Biol Res 100: 1-14
3. Beckwith JB, Kiviat NB, Bonadio JF (1990): Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 10: 1-36
4. Breslow N, Olsham A, Beckwith JB, Green DM (1993): Epidemiology of Wilms-Tumor. Med Pediatr Oncol 21: 172-181
5. Carli M, Frascella E, Tournade MF et al. (1997) Second malignant neoplasms in patients treated on SIOP Wilms' tumour studies and trials 1,2,5, and 6. Med Pediatr Oncol 29: 239-244
6. Clericuzio CL, Johnson C (1995): Screening for Wilms' tumor in high-risk individuals. Hematol Oncol Clin North Am 9: 1253-1265
7. de Kraker J, Lemerle J, Voute PA et al. (1990) Wilm's tumor with pulmonary metastases at diagnosis: the significance of primary chemotherapy. International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee. J Clin Oncol 8: 1187-1190
8. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP (1990): Homozygous deletion in Wilms' tumour of a zinc-finger gene identified by chromosome jumping. Nature 343: 774-778
9. Godzinski J, Tournade MF, deKraker J et al. (1998) Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology Trial and Study "SIOP-9". International Society of Paediatric Oncology Nephroblastoma Trial and Study Committee. Eur J Pediatr Surg 8: 83-86
10. Graf N, Zoubek A, Niggli F et al. (1999) Tumor volume and prognosis in patients with localized unilateral nephroblastoma treated preoperatively. Med Pediatr Oncol 33: 229 (P-153)
11. Graf N, Tournade MF, de Kraker J (2000) The role of preoperative chemotherapy in the management of Wilms' tumor. Urol Clin North Am 27: 443-454
12. Green DM, Coppes MJ (1995) Future directions in clinical research in Wilms' tumour. Hematol/Oncol Clin North Am 9: 1329-1339
13. Green DM, Breslow NE, Beckwith JB et al. (1998) Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 16: 237-245
14. Grundy P, Coppes MJ, Haber D (1995): Molecular Genetics of Wilms-Tumor. Hematol Oncol Clin North Am 9: 1201-1215
15. Gutjahr P, Kaatsch P, Spaar HJ et al.(1990): Klinik, Therapie und Prognose bei 373 Kindern mit Wilms-Tumoren - Ergebnisse der bundesweiten Studie 1980-1988. Acta Urol 21: 132-141
16. Huff V, Saunders GF (1993) Wilms' tumor genes. Biochim Biophys Acta 1155: 295-306
17. Huff V (1998): Wilms-tumor genetics. Am J Med Genet 79: 260-267
18. Jereb B, Tournade MF, Lemerle J et al. (1980): Lymh node invasion and prognosis in nephroblastoma. Cancer 45: 1632-1636
19. Jereb B, Burgers MV, Tournade MF et al. (1994) Radiotherapy in the SIOP (International Society of Pediatric Oncology) nephroblastoma studies: a review. Med Pediatr Oncol 22: 221-227
20. Kaatsch P, Spix C, Michaelis J (1999): Jahresbericht 1999 des Deutschen Kinderkrebsregisters (Hrsg) Deutsches Kinderkrebsregister, Mainz, S 102
21. Klamt B, Schulze M, Thäte C et al. (1998) Allele loss in Wilms-tumors of chromosome arms 11q, 16q, and 22q correlates with clinicopathological parameters. Genes Chromosomes Cancer 22: 287-294
22. Ludwig R, Weirich A, Abel U, Hofmann W, Graf N, Tournade MF (1999) Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9/GPOH. Med Pediatr Oncol 33: 462-469
23. Miller RW, Fraumeni JR, Manning MD (1964): Association of Wilms-tumor with aniridia, hemihypertrophy and other congenital anomalies. N Engl J Med 270: 922-927
24. National Wilms' Tumor Study Committee (1990) Wilms' tumor: status report. J Clin Oncol 9: 877-887
25. Pein F, Michon J, Valteau-Couanet D et al.(1998) High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study. J Clin Oncol 16: 3295-3301
26. Rance TF (1814) Causes of lung hematodes of the kidneys. Med Phys J 132: 19
27. Ritchey M, Panayotis PK, Breslow N et al. (1992): Surgical complications after nephrectomy for Wilms' tumor. Surg Gynecol Obstetr 175: 507-514
28. Stone MS, Beaver BL, Sun CCJ, Hill JL (1990): The nephroblastomatosis complex and its relationship to Wilms' tumor. J Ped Surg X: 933-938
29. Wilms M (1899) Die Mischgeschwülste der Niere. Arthur Georgie, Leipzig, S 1-90
30. Zhou J, Fogelgren B, Wang Z, Roe BA, Biegel JA (2000) Isolation of genes from the rhabdoid tumor deletion region in chromosome band 22q11.2. Gene 241: 133-141